Inspira scales up art100 production capabilities amid advanced negotiation with european government authority

Ra'anana, israel, june 05, 2025 (globe newswire) -- inspira™ technologies oxy b.h.n. ltd. (nasdaq: iinn) ("inspira," “inspira technologies,” or the "company"), a pioneer in innovative life-support and diagnostic technologies, today announced that it has scaled-up its production capabilities for its u.s. food and drug administration (fda)-cleared inspira™ art100 system (the “art100 system”), in response to expected demand from a european governmental authority with which the company is currently in advanced-stage procurement negotiations.
IINN Ratings Summary
IINN Quant Ranking